Works by Duan, Jianchun

Results: 62

Real-world analysis of immunochemotherapy in recurrent small-cell lung cancer: opportunities for second-line approaches.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1591643

By:

Guo, Yanrong;
Han, Songyan;
Guo, Qinxiang;
Zhai, Jinfang;
Ren, Xiaohui;
Li, Shengshu;
Duan, Jianchun

Publication type:

Article

Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer.

Published in:

Oncology Letters, 2017, v. 13, n. 4, p. 2425, doi. 10.3892/ol.2017.5740

By:

YUYAN WANG;
JIANCHUN DUAN;
HANXIAO CHEN;
HUA BAI;
TONGTONG AN;
JUN ZHAO;
ZHIJIE WANG;
MINGLEI ZHUO;
SHUHANG WANG;
JIE WANG

Publication type:

Article

Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors.

Published in:

2022

By:

Zhang, Pei;
Du, Yang;
Bai, Hua;
Wang, Zhijie;
Duan, Jianchun;
Wang, Xin;
Zhong, Jia;
Wan, Rui;
Xu, Jiachen;
He, Xiran;
Wang, Di;
Fei, Kailun;
Yu, Ruofei;
Tian, Jie;
Wang, Jie

Publication type:

journal article

Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2).

Published in:

BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02470-6

By:

Yang, Guangjian;
Xu, Haiyan;
Yang, Yaning;
Zhang, Shuyang;
Xu, Fei;
Hao, Xuezhi;
Li, Junling;
Xing, Puyuan;
Hu, Xingsheng;
Liu, Yutao;
Wang, Lin;
Lin, Lin;
Wang, Zhijie;
Duan, Jianchun;
Wang, Jie;
Wang, Yan

Publication type:

Article

Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2599, doi. 10.1007/s00262-020-02642-4

By:

Zhang, Fan;
Bai, Hua;
Gao, Ranran;
Fei, Kailun;
Duan, Jianchun;
Zhang, Zemin;
Wang, Jie;
Hu, Xueda

Publication type:

Article

Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non–Small Cell Lung Cancer: A Phase 1 Trial.

Published in:

JAMA Network Open, 2020, v. 3, n. 10, p. e2013770, doi. 10.1001/jamanetworkopen.2020.13770

By:

Wang, Zhijie;
Ying, Jianming;
Xu, Jiachen;
Yuan, Pei;
Duan, Jianchun;
Bai, Hua;
Guo, Changyuan;
Li, Lin;
Yang, Zhenlin;
Wan, Rui;
Fei, Kailun;
Zhao, Zhe;
Du, Xinyang;
Zhao, Junhui;
Lv, Ning;
Wang, Jie

Publication type:

Article

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non‐small cell lung cancer.

Published in:

Cell Proliferation, 2022, v. 55, n. 9, p. 1, doi. 10.1111/cpr.13283

By:

Dong, Yiting;
Zhao, Lele;
Duan, Jianchun;
Bai, Hua;
Chen, Dongsheng;
Li, Si;
Yu, Yangyang;
Xiao, Mingzhe;
Zhang, Qin;
Duan, Qianqian;
Sun, Tingting;
Qi, Chuang;
Wang, Jie;
Wang, Zhijie

Publication type:

Article

Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials

Published in:

SCIENCE CHINA Life Sciences, 2025, v. 68, n. 1, p. 249, doi. 10.1007/s11427-023-2554-y

By:

Wang, Jinliang;
Zhou, Wenyong;
Xu, Yu;
Duan, Jianchun;
Zhou, Qiaoxia;
Wang, Guoqiang;
Li, Leo;
Xu, Chunwei;
Wang, Wenxian;
Cai, Shangli;
Wang, Zhijie;
Wang, Jie

Publication type:

Article

Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC.

Published in:

PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0110780

By:

Wang, Zhijie;
Chen, Rui;
Wang, Shuhang;
Zhong, Jia;
Wu, Meina;
Zhao, Jun;
Duan, Jianchun;
Zhuo, Minglei;
An, Tongtong;
Wang, Yuyan;
Bai, Hua;
Wang, Jie

Publication type:

Article

Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer.

Published in:

PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0051021

By:

Wang, Shuhang;
An, Tongtong;
Duan, Jianchun;
Zhang, Lijian;
Wu, Meina;
Zhou, Qinghua;
Chen, Jinfeng;
Zhuo, Minglei;
Yang, Lu;
Wang, Yuyan;
Bai, Hua;
Wang, Jie

Publication type:

Article

Detection and Clinical Significance of Intratumoral <i>EGFR</i> Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer.

Published in:

PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0054170

By:

Bai, Hua;
Wang, Zhijie;
Wang, Yuyan;
Zhuo, Minglei;
Zhou, Qinghua;
Duan, Jianchun;
Yang, Lu;
Wu, Meina;
An, Tongtong;
Zhao, Jun;
Wang, Jie

Publication type:

Article

EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer.

Published in:

Oncology, 2012, v. 83, n. 5, p. 248, doi. 10.1159/000341381

By:

Wang, Zhijie;
Zhang, Xuchao;
Bai, Hua;
Zhao, Jun;
Zhuo, Minglei;
An, Tongtong;
Duan, Jianchun;
Yang, Lu;
Wu, Meina;
Wang, Shuhang;
Wang, Yuyan;
Wu, Yilong;
Wang, Jie

Publication type:

Article

IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers.

Published in:

Clinical & Translational Medicine, 2023, v. 13, n. 9, p. 1, doi. 10.1002/ctm2.1354

By:

Liu, Yutao;
Zhang, Yundi;
Xie, Wenchuan;
Zhao, Jing;
Dong, Yiting;
Xu, Chunwei;
Wang, Yanan;
Li, Man;
Wang, Guoqiang;
Zhu, Xin;
Wang, Wenxian;
Lin, Kequan;
Lu, Huafei;
Han, Yusheng;
Li, Leo;
Duan, Jianchun;
Cai, Shangli;
Wang, Jie;
Wang, Zhijie

Publication type:

Article

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients.

Published in:

2020

By:

Tian, Yanhua;
Xu, Jiachen;
Chu, Qian;
Duan, Jianchun;
Zhang, Jianjun;
Bai, Hua;
Yang, Zhenlin;
Fang, Wenfeng;
Cai, Liangliang;
Wan, Rui;
Fei, Kailun;
He, Jie;
Gao, Shugeng;
Zhang, Li;
Wang, Zhijie;
Wang, Jie

Publication type:

journal article

MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10905-3

By:

Cai, Liangliang;
Hua, Hujia;
Jiang, Xingyu;
Xu, Xintian;
Bai, Hua;
Qian, Li;
Duan, Jianchun

Publication type:

Article

Hypoxia‐inducible factor‐1α and nuclear factor‐κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non‐small‐cell lung cancer cells.

Published in:

Cancer Science, 2019, v. 110, n. 5, p. 1665, doi. 10.1111/cas.13989

By:

Guo, Rong;
Li, Yong;
Wang, Zhijie;
Bai, Hua;
Duan, Jianchun;
Wang, Shuhang;
Wang, Lvhua;
Wang, Jie

Publication type:

Article

Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy.

Published in:

Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02190-2

By:

Guo, Yufeng;
Wan, Rui;
Duan, Jianchun;
Yuan, Li;
Wang, Zhijie;
Zhong, Jia;
Zhang, Xue;
Ma, Zixiao;
Bai, Hua;
Wang, Jie

Publication type:

Article

ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations.

Published in:

Scientific Reports, 2015, p. 11392, doi. 10.1038/srep11392

By:

Wang, Zhijie;
Li, Zhenxiang;
Ding, Xiaosheng;
Shen, Zhirong;
Liu, Zhentao;
An, Tongtong;
Duan, Jianchun;
Zhong, Jia;
Wu, Meina;
Zhao, Jun;
Zhuo, Minglei;
Wang, Yuyan;
Wang, Shuhang;
Sun, Yu;
Bai, Hua;
Wang, Jie

Publication type:

Article

Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1145303

By:

Kailun Fei;
Gang Guo;
Jie Wang;
Zhijie Wang;
Yan Wang;
Xuezhi Hao;
Jia Zhong;
Qinxiang Guo;
Wei Guo;
Wenzhong Su;
Likun Zan;
Jiaxi Xu;
Fengwei Tan;
Xiaofei Zhuang;
Jianchun Duan

Publication type:

Article

Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers.

Published in:

Frontiers in Oncology, 2023, v. 12, p. 1, doi. 10.3389/fonc.2022.1099304

By:

Xinyu Wu;
Yi Fung Chau;
Hua Bai;
Xiaofei Zhuang;
Jie Wang;
Jianchun Duan

Publication type:

Article

Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future directions.

Published in:

Frontiers of Medicine, 2023, v. 17, n. 1, p. 18, doi. 10.1007/s11684-022-0976-4

By:

Zhong, Jia;
Bai, Hua;
Wang, Zhijie;
Duan, Jianchun;
Zhuang, Wei;
Wang, Di;
Wan, Rui;
Xu, Jiachen;
Fei, Kailun;
Ma, Zixiao;
Zhang, Xue;
Wang, Jie

Publication type:

Article

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations.

Published in:

Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231187205

By:

Wang, Jun;
Zhang, Bicheng;
Peng, Ling;
Liu, Xiufeng;
Sun, Jianguo;
Su, Chunxia;
Wang, Huijuan;
Zhao, Zheng;
Si, Lu;
Duan, Jianchun;
Zhang, Hongmei;
Li, Mengxia;
Zhu, Bo;
Zhang, Li;
Li, Jin;
Guo, Jun;
Luo, Rongcheng;
Qiu, Wensheng;
Ye, Dingwei;
Chu, Qian

Publication type:

Article

Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231179315

By:

Wan, Rui;
Guo, Yanrong;
Hao, Xuezhi;
Wang, Zhijie;
Duan, Jianchun;
Wang, Jie

Publication type:

Article

Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.

Published in:

Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01150-4

By:

Tian, Yanhua;
Li, Qingqing;
Yang, Zhenlin;
Zhang, Shu;
Xu, Jiachen;
Wang, Zhijie;
Bai, Hua;
Duan, Jianchun;
Zheng, Bo;
Li, Wen;
Cui, Yueli;
Wang, Xin;
Wan, Rui;
Fei, Kailun;
Zhong, Jia;
Gao, Shugeng;
He, Jie;
Gay, Carl M.;
Zhang, Jianjun;
Wang, Jie

Publication type:

Article

Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer.

Published in:

Cancers, 2022, v. 14, n. 22, p. 5649, doi. 10.3390/cancers14225649

By:

Dong, Yiting;
Zhu, Yixiang;
Zhuo, Minglei;
Chen, Xiaomin;
Xie, Yinpeng;
Duan, Jianchun;
Bai, Hua;
Hao, Shiguang;
Yu, Zicheng;
Yi, Yuting;
Guan, Yanfang;
Yuan, Jie;
Xia, Xuefeng;
Yi, Xin;
Wang, Jie;
Wang, Zhijie

Publication type:

Article

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation.

Published in:

Journal of Hematology & Oncology, 2015, v. 8, p. 1, doi. 10.1186/s13045-015-0210-9

By:

Shuhang Wang;
Xiaomei Su;
Hua Bai;
Jun Zhao;
Jianchun Duan;
Tongtong An;
Minglei Zhuo;
Zhijie Wang;
Meina Wu;
Zhenxiang Li;
Jian Zhu;
Jie Wang

Publication type:

Article

ROS1 Fusion Mediates Immunogenicity by Upregulation of PD-L1 After the Activation of ROS1–SHP2 Signaling Pathway in Non-Small Cell Lung Cancer.

Published in:

Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.527750

By:

Cai, Liangliang;
Duan, Jianchun;
Qian, Li;
Wang, Zhijie;
Wang, Shuhang;
Li, Sini;
Wang, Chao;
Zhao, Jie;
Zhang, Xue;
Bai, Hua;
Wang, Jie

Publication type:

Article

Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-13068-x

By:

Shen, Fangfang;
Wu, Xinyu;
Geng, Jiang;
Guo, Wei;
Duan, Jianchun

Publication type:

Article

Combined Immunotherapy with Chemotherapy versus Bevacizumab with Chemotherapy in First-Line Treatment of Driver-Gene-Negative Non-Squamous Non-Small Cell Lung Cancer: An Updated Systematic Review and Network Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1655, doi. 10.3390/jcm11061655

By:

Chai, Yue;
Wu, Xinyu;
Bai, Hua;
Duan, Jianchun

Publication type:

Article

Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment.

Published in:

Thoracic Cancer, 2023, v. 14, n. 19, p. 1843, doi. 10.1111/1759-7714.14929

By:

Wang, Chao;
Fei, Kailun;
Liu, Lihui;
Duan, Jianchun;
Wang, Zhijie;
Li, Sini;
Xu, Jiachen;
Zhang, Xue;
Tian, Yanhua;
Qu, Yan;
Bai, Hua;
Wang, Jie

Publication type:

Article

Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An updated systematic review and meta‐analysis

Published in:

Thoracic Cancer, 2022, v. 13, n. 22, p. 3124, doi. 10.1111/1759-7714.14664

By:

Chai, Yue;
Wu, Xinyu;
Zou, Yifeng;
Zhang, Xue;
Bai, Hua;
Dong, Mei;
Duan, Jianchun

Publication type:

Article

Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non–small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 21, p. 2951, doi. 10.1111/1759-7714.14635

By:

Chang, Geyun;
Li, Weihua;
Bai, Hua;
Duan, Jianchun;
Wang, Zhijie;
Du, Xinyang;
Yu, Ruofei;
Wang, Yaxi;
Wang, Minghao;
Zhu, Yixiang;
Zhang, Xue;
Li, Li;
Wan, Rui;
Wang, Jie

Publication type:

Article

Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.

Published in:

Thoracic Cancer, 2021, v. 12, n. 23, p. 3273, doi. 10.1111/1759-7714.14133

By:

Li, Shuluan;
Zhang, Pei;
Wang, Tianyu;
Wang, Jie;
Duan, Jianchun

Publication type:

Article

Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer.

Published in:

Thoracic Cancer, 2021, v. 12, n. 20, p. 2732, doi. 10.1111/1759-7714.14114

By:

Du, Jun;
Zhang, Yundi;
Dong, Yiting;
Duan, Jianchun;
Bai, Hua;
Wang, Jie;
Xu, Jiachen;
Wang, Zhijie

Publication type:

Article

Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer.

Published in:

Thoracic Cancer, 2021, v. 12, n. 1, p. 66, doi. 10.1111/1759-7714.13711

By:

Zhao, Zhe;
Fei, Kailun;
Bai, Hua;
Wang, Zhijie;
Duan, Jianchun;
Wang, Jie

Publication type:

Article

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2021, v. 12, n. 1, p. 30, doi. 10.1111/1759-7714.13685

By:

Zhang, Pei;
Duan, Jianchun;
Bai, Hua;
Wang, Zhijie;
Gao, Shugeng;
Tan, Fengwei;
Gao, Yushun;
Wang, Xin;
Wan, Rui;
Xu, Jiachen;
He, Xiran;
Feng, Xiaoshuang;
Yu, Ruofei;
Sun, Jing;
Zhao, Zhe;
Fei, Kailun;
Li, Ni;
He, Jie;
Wang, Jie

Publication type:

Article

Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID‐19 epidemic.

Published in:

Thoracic Cancer, 2020, v. 11, n. 6, p. 1752, doi. 10.1111/1759-7714.13424

By:

Zhao, Zhe;
Bai, Hua;
Duan, Jianchun;
Wang, Jie

Publication type:

Article

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma.

Published in:

Thoracic Cancer, 2020, v. 11, n. 5, p. 1149, doi. 10.1111/1759-7714.13356

By:

Wang, Shuhang;
Liang, Qiuping;
Chi, Yujia;
Zhuo, Minglei;
An, Tongtong;
Duan, Jianchun;
Wang, Zhijie;
Wang, Yuyan;
Zhong, Jia;
Yang, Xue;
Chen, Hanxiao;
Wang, Jie;
Zhao, Jun

Publication type:

Article

Pegylated recombinant human granulocyte colony‐stimulating factor regulates the immune status of patients with small cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 3, p. 713, doi. 10.1111/1759-7714.13322

By:

Sun, Jing;
Bai, Hua;
Wang, Zhijie;
Duan, Jianchun;
Li, Jin;
Guo, Ruimin;
Wang, Jie

Publication type:

Article

Prognostic significance of molecular characteristics of cerebrospinal fluid for non‐small cell lung cancer patients with leptomeningeal metastasis.

Published in:

Thoracic Cancer, 2019, v. 10, n. 8, p. 1673, doi. 10.1111/1759-7714.13123

By:

Li, Ning;
Liu, Yutao;
Duan, Jianchun;
Yang, Boyan;
Bai, Hua;
Sun, Rui;
Yu, Lei;
Wang, Jie

Publication type:

Article

Impact of PD‐L1, transforming growth factor‐β expression and tumor‐infiltrating CD8<sup>+</sup> T cells on clinical outcome of patients with advanced thymic epithelial tumors.

Published in:

Thoracic Cancer, 2018, v. 9, n. 11, p. 1341, doi. 10.1111/1759-7714.12826

By:

Duan, Jianchun;
Liu, Xidong;
Chen, Han;
Sun, Yu;
Liu, Yiqiang;
Bai, Hua;
Wang, Jie

Publication type:

Article

Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer.

Published in:

Thoracic Cancer, 2018, v. 9, n. 9, p. 1166, doi. 10.1111/1759-7714.12819

By:

Lv, Chunxin;
Liu, Xiuju;
Zheng, Qiwen;
Chen, Hanxiao;
Yang, Xue;
Zhong, Jia;
Wang, Yuyan;
Duan, Jianchun;
Wang, Zhijie;
Bai, Hua;
Wu, Meina;
Zhao, Jun;
Wang, Jie;
Wang, Ziping;
An, Tongtong;
Zhuo, Minglei

Publication type:

Article

Efficacy and safety of weekly intravenous nanoparticle albumin-bound paclitaxel for non-small cell lung cancer patients who have failed at least two prior systemic treatments.

Published in:

Thoracic Cancer, 2017, v. 8, n. 3, p. 138, doi. 10.1111/1759-7714.12413

By:

Duan, Jianchun;
Hao, Yueqin;
Wan, Rui;
Yu, Sifan;
Bai, Hua;
An, Tongtong;
Zhao, Jun;
Wang, Zhijie;
Zhuo, Minglei;
Wang, Jie

Publication type:

Article

High-fidelity of non-small cell lung cancer xenograft models derived from bronchoscopy-guided biopsies.

Published in:

Thoracic Cancer, 2016, v. 7, n. 1, p. 100, doi. 10.1111/1759-7714.12291

By:

Fu, Shuai;
Zhao, Jun;
Bai, Hua;
Duan, Jianchun;
Wang, Zhijie;
An, Tongtong;
Wang, Jie

Publication type:

Article

Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma.

Published in:

Thoracic Cancer, 2015, v. 6, n. 3, p. 269, doi. 10.1111/1759-7714.12177

By:

Li, Zhenxiang;
Jiang, Leilei;
Bai, Hua;
Wang, Zhijie;
Zhao, Jun;
Duan, Jianchun;
Yang, Xiaodan;
An, Tongtong;
Wang, Jie

Publication type:

Article

Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung.

Published in:

Thoracic Cancer, 2015, v. 6, n. 3, p. 319, doi. 10.1111/1759-7714.12204

By:

Duan, Jianchun;
Wang, Zhijie;
Bai, Hua;
An, Tongtong;
Zhuo, Minglei;
Wu, Meina;
Wang, Yuyan;
Yang, Lu;
Wang, Jie

Publication type:

Article

Patients harboring epidermal growth factor receptor ( EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors.

Published in:

Thoracic Cancer, 2014, v. 5, n. 2, p. 126, doi. 10.1111/1759-7714.12068

By:

Wei, Zhigang;
An, Tongtong;
Wang, Zhijie;
Chen, Keneng;
Bai, Hua;
Zhu, Guangying;
Duan, Jianchun;
Wu, Meina;
Yang, Lu;
Zhuo, Minglei;
Wang, Yuyan;
Liu, Xuyi;
Wang, Jie

Publication type:

Article

The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI.

Published in:

2012

By:

Huang, Zhen;
Wang, Zhijie;
Bai, Hua;
Wu, Meina;
An, Tongtong;
Zhao, Jun;
Yang, Lu;
Duan, Jianchun;
Zhuo, Minglei;
Wang, Yuyan;
Wang, Shuhang;
Wang, Jie

Publication type:

Journal Article

The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI.

Published in:

Thoracic Cancer, 2012, v. 3, n. 4, p. 334, doi. 10.1111/j.1759-7714.2012.00133.x

By:

Huang, Zhen;
Wang, Zhijie;
Bai, Hua;
Wu, Meina;
An, Tongtong;
Zhao, Jun;
Yang, Lu;
Duan, Jianchun;
Zhuo, Minglei;
Wang, Yuyan;
Wang, Shuhang;
Wang, Jie

Publication type:

Article

Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2024, v. 15, n. 13, p. 1050, doi. 10.1111/1759-7714.15295

By:

Zhao, Jie;
Zhuang, Wei;
Sun, Boyang;
Bai, Hua;
Wang, Zhijie;
Zhong, Jia;
Wan, Rui;
Liu, Lihui;
Duan, Jianchun;
Wang, Jie

Publication type:

Article